EveryLife Issues Statement on Rare Disease Community’s Drug Pricing Considerations March 16, 2022 Share this page Senate Finance Committee Hearing, Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare Drug Pricing Related Articles The Updated Substantial Evidence Guidance September 28, 2026 Bipartisan Bill Introduced to Fund State Implementation of Newborn Screening Conditions September 25, 2026 Medical Frailty Tier System Guidance September 17, 2026 See All News